Stay updated on Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial
Sign up to get notified when there's something new on the Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial page.

Latest updates to the Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check9 days agoChange DetectedThe page has removed the previous version of the treatment information regarding Oral Azacitidine combined with Venetoclax for higher-risk Myelodysplastic Syndromes and replaced it with a new version dated May 21, 2025.SummaryDifference5%
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check45 days agoChange DetectedThe web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content. The phrase 'Here’s how you know' has been modified, suggesting a change in the way information is presented.SummaryDifference1.0%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check96 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
Stay in the know with updates to Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Azacitidine + Venetoclax in Untreated MDS Clinical Trial page.